Kindred Healthcare (KND) Earning Positive Press Coverage, Report Finds
News stories about Kindred Healthcare (NYSE:KND) have been trending positive recently, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Kindred Healthcare earned a news impact score of 0.25 on Accern’s scale. Accern also gave news articles about the health services provider an impact score of 45.7943565006764 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Kindred Healthcare (NYSE:KND) traded up $0.10 during midday trading on Friday, hitting $7.45. The stock had a trading volume of 1,139,826 shares, compared to its average volume of 1,334,493. The firm has a market cap of $647.65, a price-to-earnings ratio of 37.25 and a beta of 1.20. Kindred Healthcare has a fifty-two week low of $5.50 and a fifty-two week high of $11.90. The company has a quick ratio of 1.53, a current ratio of 1.55 and a debt-to-equity ratio of 6.22.
Kindred Healthcare (NYSE:KND) last released its quarterly earnings data on Monday, November 6th. The health services provider reported ($0.11) earnings per share for the quarter, beating the consensus estimate of ($0.19) by $0.08. The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.44 billion. Kindred Healthcare had a positive return on equity of 2.29% and a negative net margin of 8.06%. The company’s revenue was down 5.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.05 EPS. equities analysts expect that Kindred Healthcare will post 0.27 earnings per share for the current fiscal year.
A number of analysts have issued reports on KND shares. Zacks Investment Research raised Kindred Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, August 11th. ValuEngine raised Kindred Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday, November 9th. Deutsche Bank decreased their price target on Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday, August 7th. Stifel Nicolaus raised Kindred Healthcare from a “sell” rating to a “hold” rating and set a $7.00 price target on the stock in a research note on Monday, November 20th. Finally, Bank of America decreased their price target on Kindred Healthcare from $7.50 to $6.50 and set an “underperform” rating on the stock in a research note on Thursday, September 21st. Two analysts have rated the stock with a sell rating, seven have given a hold rating and one has assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $8.86.
Kindred Healthcare Company Profile
Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.
Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.